North Coast Technology Investors

Founded in 1998, North Coast is a Michigan-based venture capital firm focusing on early-stage technology companies in the United States. They primarily invest in healthcare, software, and communications technology sectors, often being the first or sole investor.

Lindsay Aspegren

General Partner

Hugo Braun

Co-Founder

Past deals in Michigan

Delphinus Medical Technologies

Series D in 2022
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with an additional office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing innovative breast cancer screening solutions. Its flagship product, SoftVue, employs a unique circular array transducer technology that utilizes ultrasound to provide three-dimensional and tomographic imaging of the entire breast. This system is designed to differentiate between benign and malignant masses, assess breast cancer risks, and monitor treatment, all while ensuring a comfortable experience for patients without the use of radiation. Delphinus serves hospitals and imaging clinics both in the United States and internationally, aiming to improve early detection and diagnosis of breast cancer.

BlueWillow Biologics

Series A in 2018
BlueWillow Biologics, Inc. is a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializing in the development of intranasal vaccines and anti-infective products utilizing patented nanotechnology. Founded as a spin-off from the University of Michigan in 1999, the company focuses on creating vaccines that provide mucosal immunity against respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, HSV2, chlamydia, and HIV. Its innovative NanoStat vaccine technology features an oil-in-water nanoemulsion that effectively incorporates and delivers multiple antigens while enhancing immune responses. In addition to its vaccine portfolio, BlueWillow Biologics offers NanoBio Protect, a nasal antiseptic solution. The company has established partnerships, including a licensing agreement with Merck for its adjuvant technology and a strategic alliance with Public Health England to further its mission in combating infectious diseases.

Delphinus Medical Technologies

Series C in 2015
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with an additional office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing innovative breast cancer screening solutions. Its flagship product, SoftVue, employs a unique circular array transducer technology that utilizes ultrasound to provide three-dimensional and tomographic imaging of the entire breast. This system is designed to differentiate between benign and malignant masses, assess breast cancer risks, and monitor treatment, all while ensuring a comfortable experience for patients without the use of radiation. Delphinus serves hospitals and imaging clinics both in the United States and internationally, aiming to improve early detection and diagnosis of breast cancer.

VNN

Venture Round in 2015
VNN, Inc. operates a prominent high school sports marketing and networking platform that serves as a digital hub for athletes, coaches, and fans. The platform enables athletes to upload videos, photos, stories, and scores, while allowing coaches to report game results to various media outlets. VNN is dedicated to enhancing the experience of high school sports by aggregating the fragmented market and providing advertising and promotional services. The company has established a significant presence, serving schools across multiple states, including Alabama, California, and Texas, and has gained a rapidly growing user base, with over 7 million fans engaging with the platform daily. Founded in 2010 and based in Grand Rapids, Michigan, VNN aims to transform the consumer experience in high school sports by leveraging technology and connectivity.

VNN

Series A in 2014
VNN, Inc. operates a prominent high school sports marketing and networking platform that serves as a digital hub for athletes, coaches, and fans. The platform enables athletes to upload videos, photos, stories, and scores, while allowing coaches to report game results to various media outlets. VNN is dedicated to enhancing the experience of high school sports by aggregating the fragmented market and providing advertising and promotional services. The company has established a significant presence, serving schools across multiple states, including Alabama, California, and Texas, and has gained a rapidly growing user base, with over 7 million fans engaging with the platform daily. Founded in 2010 and based in Grand Rapids, Michigan, VNN aims to transform the consumer experience in high school sports by leveraging technology and connectivity.

Delphinus Medical Technologies

Series B in 2013
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with an additional office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing innovative breast cancer screening solutions. Its flagship product, SoftVue, employs a unique circular array transducer technology that utilizes ultrasound to provide three-dimensional and tomographic imaging of the entire breast. This system is designed to differentiate between benign and malignant masses, assess breast cancer risks, and monitor treatment, all while ensuring a comfortable experience for patients without the use of radiation. Delphinus serves hospitals and imaging clinics both in the United States and internationally, aiming to improve early detection and diagnosis of breast cancer.

Livio Radio

Series C in 2012
Livio Radio, operating under Myine Electronics, LLC, specializes in designing and manufacturing electronic audio products. Founded in 2008 and based in Ferndale, Michigan, the company offers a range of Bluetooth Internet radio solutions for smartphones, including iPhones and Android devices, as well as car audio players for both personal and business use. In addition to its hardware, Livio Radio provides the Livio Connect API, a middleware framework that facilitates the interaction between hardware and various mobile phone applications. Its products are distributed through a network of retailers, resellers, and online platforms.

Delphinus Medical Technologies

Series A in 2010
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with an additional office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing innovative breast cancer screening solutions. Its flagship product, SoftVue, employs a unique circular array transducer technology that utilizes ultrasound to provide three-dimensional and tomographic imaging of the entire breast. This system is designed to differentiate between benign and malignant masses, assess breast cancer risks, and monitor treatment, all while ensuring a comfortable experience for patients without the use of radiation. Delphinus serves hospitals and imaging clinics both in the United States and internationally, aiming to improve early detection and diagnosis of breast cancer.

Arbortext

Venture Round in 2003
Arbortext is a company that specializes in XML-based software solutions designed for content creation, editing, and publishing across multiple channels. Founded in December 1982 and headquartered in Ann Arbor, Michigan, Arbortext offers enterprise software and authoring tools that facilitate the production of extensive information in various languages and electronic formats. The company's solutions are particularly valuable for organizations needing to manage and disseminate significant volumes of content efficiently. Arbortext has been recognized for its contributions to the field, and it operates under the ownership of Parametric Technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.